D-Glutamate

D-Glutamate

SCHEMBL939698

C#C.C#C.NC(CCC(=O)O)C(=O)O

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM8 O00222 2/20 0.90
▸ GRM6 O15303 2/20 0.90
▸ GRM7 Q14831 2/20 0.90
▸ GRM4 Q14833 2/20 0.90
▸ GSR P00390 2/20 0.90
▸ GRIN2D O15399 1/20 0.90
▸ GRIN3B O60391 1/20 0.90
▸ CYP1A2 P05177 1/20 0.90
▸ GRIK1 P39086 1/20 0.90
▸ GRM5 P41594 1/20 0.90
▸ GRIA1 P42261 1/20 0.90
▸ GRIA2 P42262 1/20 0.90
▸ GRIA3 P42263 1/20 0.90
▸ SLC1A3 P43003 1/20 0.90
▸ SLC1A2 P43004 1/20 0.90
▸ SLC1A1 P43005 1/20 0.90
▸ GRIA4 P48058 1/20 0.90
▸ GRIN1 Q05586 1/20 0.90
▸ GRIN2A Q12879 1/20 0.90
▸ GRIK2 Q13002 1/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamic Acid SCHEMBL939699 1.00 GRM8 (0.90) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL1554237 0.95 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL1330566 0.95 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL5704264 0.95 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL2202 0.95 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL410241 0.95 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL1332144 0.95 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL1330917 0.95 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL1332007 0.95 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL43222 0.95 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107311887-B A kind of method of visible identification chiral sulfenamide 中国科学院化学研究所 2019-02-26 — — CN disclosed
CN-107311887-B A kind of method of visible identification chiral sulfenamide 中国科学院化学研究所 2019-02-26 — — CN disclosed
CN-107311887-A A kind of method of visible identification chiral sulfenamide 中国科学院化学研究所 2017-11-03 — — CN disclosed
CN-107311887-A A kind of method of visible identification chiral sulfenamide 中国科学院化学研究所 2017-11-03 — — CN disclosed
US-20130040020-A1 Methods and Compositions for Preparing Consumables with Optical Shifting Properties SEGAN INDUSTRIES, INC. 2013-02-14 — — US disclosed
US-20110008498-A1 Methods and Compositions for Preparing Consumables with Optical Shifting Properties SEGAN INDUSTRIES, INC. 2011-01-13 — — US disclosed
US-7776371-B2 Methods and compositions for preparing consumables with optical shifting properties SEGAN INDUSTRIES INC. (US) 2010-08-17 — — US disclosed
EP-2128610-A2 Ingestibles possessing intrinsic color change Segan Industries, Inc. (US) 2009-12-02 — — EP disclosed
US-20070071680-A1 Methods and compositions for preparing consumables with optical shifting properties SEGAN INDUSTRIES, INC. 2007-03-29 — — US disclosed
US-6866863-B2 Ingestibles possessing intrinsic color change SEGAN INDUSTRIES, INC. (US) 2005-03-15 — — US disclosed
US-6607744-B1 Polydiacetylene homopolymer triggered to change color at transition temperature; foods, drinks SEGAN INDUSTRIES 2003-08-19 — — US disclosed
US-20030143188-A1 Ingestibles possessing intrinsic color change SEGAN INDUSTRIES 2003-07-31 — — US disclosed
US-20030103905-A1 Methods and compositions for preparing consumables with optical shifting properties SEGAN INDUSTRIES 2003-06-05 — — US disclosed
EP-1297333-A2 INGESTIBLES POSSESSING INTRINSIC COLOR CHANGE Segan Industries, Inc. (US) 2003-04-02 — — EP disclosed
US-20020034475-A1 Ingestibles possessing intrinsic color change SEGAN INDUSTRIES 2002-03-21 — — US disclosed
WO-2002000920-A2 INGESTIBLES POSSESSING INTRINSIC COLOR CHANGE SEGAN INDUSTRIES, INC. (US) 2002-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030103905-A1 Methods and compositions for preparing consumables with optical shifting properties TAS2R46, THEM6, TAS2R41 GRM8 3344/4885GRM6 855/4885GRM7 3511/4885
US-20020034475-A1 Ingestibles possessing intrinsic color change TAS2R46, THEM6, TAS2R16 GRM8 3561/4885GRM6 1225/4885GRM7 3553/4885
US-20070071680-A1 Methods and compositions for preparing consumables with optical shifting properties TAS2R46, THEM6, TAS2R41 GRM8 3344/4885GRM6 855/4885GRM7 3511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback